The relative contributions of antithrombin iii during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.
- 1 May 1987
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 46 (4) , 539-553
- https://doi.org/10.1016/0049-3848(87)90155-1
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Antithrombin III in patients with acute deep vein thrombosis during heparin treatment (subcutaneous and intravenous) and during and after treatment with oral coumarinsThrombosis Research, 1984
- THE PHENOMENON OF THE ACUTE PHASE RESPONSE*Annals of the New York Academy of Sciences, 1982
- Antithrombin III levels during heparin therapyThrombosis Research, 1981
- Activation of factor X and prothrombin in antithrombin-III depleted plasma: The effects of heparinThrombosis Research, 1981
- Properties of antithrombin III depleted plasma I. Effect of heparinThrombosis Research, 1980
- Impedance plethysmography: the relationship between venous filling and sensitivity and specificity for proximal vein thrombosis.Circulation, 1978
- Comparison of the inhibition of thrombin by three plasma protease inhibitorsBiochemistry, 1978
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977
- Heparin kinetics in venous thrombosis and pulmonary embolism.Circulation, 1976
- Immunological Studies on Human Antithrombin IIIScandinavian Journal of Haematology, 1970